A COVID-19 vaccine developed jointly by a Taiwanese biomedical company and the United States National Institutes of Health (NIH) has been given conditional approval to enter human trials, Taiwan's Food and Drug Administration (FDA) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
10/31/2025 09:10 AM - Politics
KMT pushes disaster rebuilding bill amid warnings of past mistakes
10/30/2025 10:17 PM - Cross-Strait
China-born spouse loses Taiwan citizenship over national security concerns
10/30/2025 09:47 PM - Politics
Taiwan to unveil 2050 circular economy roadmap in 2026: President Lai
10/30/2025 09:25 PM - Society
Cabinet policy to allow more migrant workers slammed by labor groups
10/30/2025 08:55 PM